
UK regulatory affairs provider the ELC Group has confirmed the appointment of clinical pharmacologist Dr Siddharth Chachad as its head …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

